Showing results (481-490 of 3,716) with videos related to
Sort By:
Pageof 372
Investigational New Drugs|January 1, 1997
Prolonged infusion gemcitabine: a clinical phase I study at low- (300 mg/m2) and high-dose (875 mg/m2) levelsC F Pollera, A Ceribelli, M Crecco, et al.Investigational New Drugs|January 1, 1997
Phase II trial of oral piritrexim in advanced, previously treated transitional cell cancer of bladderM Khorsand, J Lange, L Feun, et al.Investigational New Drugs|January 1, 1997
An ECOG phase II study of amonafide in unresectable or recurrent carcinoma of the head and neck (PB390). Eastern Cooperative Oncology GroupA N Leaf, D Neuberg, E L Schwartz, et al.Investigational New Drugs|January 1, 1997
Matrix metalloproteinase inhibitorsS M Wojtowicz-Praga, R B Dickson, M J HawkinsInvestigational New Drugs|November 26, 2009
Inhibitory effects of tea polyphenols by targeting cyclooxygenase-2 through regulation of nuclear factor kappa B, Akt and p53 in rat mammary tumorsPreeti Roy, Jasmine George, Smita Srivastava, et al.Investigational New Drugs|December 17, 2009
Anti-tumor activity and mechanisms of a novel vascular disrupting agent, (Z)-3,4',5-trimethoxylstilbene-3'-O-phosphate disodium (M410)Yu-Chen Cai, Yong Zou, Yan-Li Ye, et al.Investigational New Drugs|December 17, 2009
Luteolin inhibits cell proliferation during Azoxymethane-induced experimental colon carcinogenesis via Wnt/ β-catenin pathwayPandurangan Ashokkumar, Ganapasam SudhandiranInvestigational New Drugs|December 5, 2009
Antitumor effect of BPR-DC-2, a novel synthetic cyclic cyanoguanidine derivative, involving the inhibition of MDR-1 expression and down-regulation of p-AKT and PARP-1 in lung cancerShun-Lai Li, Chia-Hsin Huang, Chih-Chan Lin, et al.Investigational New Drugs|August 1, 1992
A phase I pharmacokinetic study of recombinant human tumor necrosis factor administered by a 5-day continuous infusionA Mittelman, C Puccio, E Gafney, et al.Investigational New Drugs|August 1, 1992
A phase II study of interleukin-2 and interferon-alpha in head and neck cancerS P Schantz, I Dimery, S M Lippman, et al.Pageof 372